‘Temperature Abuse’ Heated US Drug Recalls To Record Level In FY2022, FDA Finds

Surveillance inspections nearly tripled as drug recalls reached highest level in five years, finds agency’s FY 2022 “state of pharmaceutical quality” report. Meanwhile, analysis points to lack of domestic API sources for many essential medicines.